Jazz Pharmaceuticals plc (JAZZ)
NASDAQ: JAZZ · Real-Time Price · USD
203.98
+2.76 (1.37%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Jazz Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 12,557 | 10,330 | 7,445 | 7,744 | 10,031 | 7,831 | Upgrade
|
| Market Cap Growth | 102.61% | 38.75% | -3.86% | -22.80% | 28.09% | -14.84% | Upgrade
|
| Enterprise Value | 15,542 | 13,713 | 11,032 | 11,945 | 14,946 | 13,570 | Upgrade
|
| Last Close Price | 203.98 | 170.00 | 123.15 | 123.00 | 159.31 | 127.40 | Upgrade
|
| PE Ratio | - | - | 13.29 | 18.67 | - | - | Upgrade
|
| Forward PE | 8.44 | 7.67 | 5.72 | 6.29 | 8.54 | 8.23 | Upgrade
|
| PS Ratio | 2.94 | 2.42 | 1.83 | 2.02 | 2.74 | 2.53 | Upgrade
|
| PB Ratio | 2.90 | 2.39 | 1.82 | 2.07 | 3.25 | 1.98 | Upgrade
|
| P/FCF Ratio | 9.68 | 7.96 | 5.48 | 7.25 | 8.07 | 10.43 | Upgrade
|
| P/OCF Ratio | 9.26 | 7.62 | 5.33 | 7.09 | 7.89 | 10.06 | Upgrade
|
| PEG Ratio | 0.15 | 0.55 | 0.37 | 0.50 | 1.14 | 0.62 | Upgrade
|
| EV/Sales Ratio | 3.64 | 3.21 | 2.71 | 3.12 | 4.08 | 4.39 | Upgrade
|
| EV/EBITDA Ratio | 9.07 | 8.00 | 7.24 | 8.21 | 10.18 | 13.20 | Upgrade
|
| EV/EBIT Ratio | 15.27 | 13.47 | 12.77 | 14.63 | 17.81 | 28.55 | Upgrade
|
| EV/FCF Ratio | 11.98 | 10.57 | 8.13 | 11.18 | 12.03 | 18.07 | Upgrade
|
| Debt / Equity Ratio | 1.26 | 1.26 | 1.51 | 1.55 | 1.89 | 1.56 | Upgrade
|
| Debt / EBITDA Ratio | 3.11 | 3.11 | 3.97 | 3.92 | 3.90 | 5.84 | Upgrade
|
| Debt / FCF Ratio | 4.18 | 4.18 | 4.54 | 5.43 | 4.68 | 8.22 | Upgrade
|
| Net Debt / Equity Ratio | 0.69 | 0.69 | 0.78 | 1.12 | 1.60 | 1.41 | Upgrade
|
| Net Debt / EBITDA Ratio | 1.74 | 1.74 | 2.08 | 2.87 | 3.36 | 5.43 | Upgrade
|
| Net Debt / FCF Ratio | 2.30 | 2.30 | 2.34 | 3.90 | 3.97 | 7.44 | Upgrade
|
| Asset Turnover | 0.36 | 0.36 | 0.35 | 0.35 | 0.32 | 0.33 | Upgrade
|
| Inventory Turnover | 0.79 | 0.79 | 0.58 | 0.43 | 0.30 | 0.37 | Upgrade
|
| Quick Ratio | 1.46 | 1.46 | 3.57 | 1.52 | 1.64 | 1.43 | Upgrade
|
| Current Ratio | 1.86 | 1.86 | 4.46 | 2.24 | 2.79 | 3.23 | Upgrade
|
| Return on Equity (ROE) | -8.47% | -8.47% | 14.31% | 12.16% | -6.35% | -8.65% | Upgrade
|
| Return on Assets (ROA) | 5.38% | 5.38% | 4.61% | 4.59% | 4.53% | 3.15% | Upgrade
|
| Return on Invested Capital (ROIC) | 13.90% | 13.97% | 11.39% | 10.25% | 9.55% | 7.13% | Upgrade
|
| Return on Capital Employed (ROCE) | 10.80% | 10.80% | 7.90% | 8.30% | 8.50% | 4.10% | Upgrade
|
| Earnings Yield | -2.84% | -3.45% | 7.52% | 5.36% | -2.23% | -4.21% | Upgrade
|
| FCF Yield | 10.33% | 12.56% | 18.24% | 13.79% | 12.39% | 9.59% | Upgrade
|
| Buyback Yield / Dilution | 7.61% | 7.61% | 8.41% | -15.23% | -4.77% | -5.62% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.